High-dose bee venom exposure induces similar tolerogenic B-cell responses in allergic patients and healthy beekeepers

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 72, Issue 3, 2017, Pages 407-415

  Boonpiyathad, T ^a,b,c,d   Meyer, N ^e   Moniuszko, M ^f   Sokolowska, M ^a   Eljaszewicz, A ^a,f   Wirz, O F ^a   Tomasiak Lozowska, M M ^f   Bodzenta Lukaszyk, A ^f   Ruxrungtham, K ^c   van de Veen, W ^a,d  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b PHRAMONGKUTKLAO HOSPITAL   (Thailand)

^c CHULALONGKORN UNIVERSITY   (Thailand)

^d CHRISTINE KÜHNE CENTER FOR ALLERGY RESEARCH AND EDUCATION CK CARE   (Switzerland)

^e UNIVERSITY OF BERN   (Switzerland)

^f MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

allergen specific immunotherapy; bee venom allergy; CCR5; IgG4; immune tolerance; Regulatory B cells

Indexed keywords

5' NUCLEOTIDASE; BEE VENOM; CD71 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR5; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN HEAVY CHAIN; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; PHOSPHOLIPASE A2; ALLERGEN; BIOLOGICAL MARKER; CYTOKINE; IMMUNOGLOBULIN G;

ARTICLE; B LYMPHOCYTE; BEE VENOM ALLERGY; BEEKEEPER; CELL EXPANSION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOTHERAPY; INFLAMMATION; INSECT ALLERGY; MEMORY CELL; NONMEDICAL OCCUPATIONS; PHENOTYPE; PLASMABLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; B LYMPHOCYTE SUBPOPULATION; BIOSYNTHESIS; BLOOD; DESENSITIZATION; DOSE RESPONSE; ENVIRONMENTAL EXPOSURE; HYPERSENSITIVITY; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; METABOLISM; OCCUPATIONAL EXPOSURE; PROCEDURES;

ALLERGENS; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; BEE VENOMS; BIOMARKERS; CYTOKINES; DESENSITIZATION, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENVIRONMENTAL EXPOSURE; HUMANS; HYPERSENSITIVITY; IMMUNE TOLERANCE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; OCCUPATIONAL EXPOSURE; PHOSPHOLIPASES A2;

EID: 84978758590     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12966     Document Type: Article

References (44)

1. Akdis CA, Akdis M. Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens. World Allergy Organ J 2015;8:17.
2. Boyle RJ, Elremeli M, Hockenhull J, Cherry MG, Bulsara MK, Daniels M et al. Venom immunotherapy for preventing allergic reactions to insect stings. Cochrane Database Syst Rev 2012;10:CD008838.
3. Akdis CA, Akdis M, Blesken T, Wymann D, Alkan SS, Muller U et al. Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J Clin Invest 1996;98:1676–1683.
4. Meiler F, Zumkehr J, Klunker S, Ruckert B, Akdis CA, Akdis M. In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J Exp Med 2008;205:2887–2898.
5. Akdis CA, Akdis M. Mechanisms of immune tolerance to allergens: role of IL-10 and Tregs. J Clin Invest 2014;124:4678–4680.
6. Meiler F, Klunker S, Zimmermann M, Akdis CA, Akdis M. Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll-like receptors. Allergy 2008;63:1455–1463.
7. Satoguina JS, Weyand E, Larbi J, Hoerauf A. T regulatory-1 cells induce IgG4 production by B cells: role of IL-10. J Immunol 2005;174:4718–4726.
8. Palomares O, Martin-Fontecha M, Lauener R, Traidl-Hoffmann C, Cavkaytar O, Akdis M et al. Regulatory T cells and immune regulation of allergic diseases: roles of IL-10 and TGF-beta. Genes Immun 2014;15:511–520.
9. Santos AF, James LK, Bahnson HT, Shamji MH, Couto-Francisco NC, Islam S et al. IgG4 inhibits peanut-induced basophil and mast cell activation in peanut-tolerant children sensitized to peanut major allergens. J Allergy Clin Immunol 2015;135:1249–1256.
10. Wachholz PA, Soni NK, Till SJ, Durham SR. Inhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy. J Allergy Clin Immunol 2003;112:915–922.
11. Hoh RA, Joshi SA, Liu Y, Wang C, Roskin KM, Lee JY et al. Single B-cell deconvolution of peanut-specific antibody responses in allergic patients. J Allergy Clin Immunol 2015;137:157–167.
12. Van Ree R, Van Leeuwen WA, Dieges PH, Van Wijk RG, De Jong N, Brewczyski PZ et al. Measurement of IgE antibodies against purified grass pollen allergens (Lol p 1, 2, 3 and 5) during immunotherapy. Clin Exp Allergy 1997;27:68–74.
13. Jutel M, Jaeger L, Suck R, Meyer H, Fiebig H, Cromwell O. Allergen-specific immunotherapy with recombinant grass pollen allergens. J Allergy Clin Immunol 2005;116:608–613.
14. Chliva C, Aggelides X, Makris M, Katoulis A, Rigopoulos D, Tiligada E. Comparable profiles of serum histamine and IgG4 levels in allergic beekeepers. Allergy 2015;70:457–460.
15. Pape KA, Taylor JJ, Maul RW, Gearhart PJ, Jenkins MK. Different B cell populations mediate early and late memory during an endogenous immune response. Science 2011;331:1203–1207.
16. Griffith JW, Sokol CL, Luster AD. Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu Rev Immunol 2014;32:659–702.
17. Chang LY, Lin YC, Kang CW, Hsu CY, Chu YY, Huang CT et al. The indispensable role of CCR5 for in vivo suppressor function of tumor-derived CD103+ effector/memory regulatory T cells. J Immunol 2012;189:567–574.
18. Gardner LM, Thien FC, Douglass JA, Rolland JM, O'Hehir RE. Induction of T ‘regulatory’ cells by standardized house dust mite immunotherapy: an increase in CD4+ CD25+ interleukin-10+ T cells expressing peripheral tissue trafficking markers. Clin Exp Allergy 2004;34:1209–1219.
19. Wysocki CA, Jiang Q, Panoskaltsis-Mortari A, Taylor PA, McKinnon KP, Su L et al. Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease. Blood 2005;106:3300–3307.
20. Sturm G, Kranke B, Rudolph C, Aberer W. Rush hymenoptera venom immunotherapy: a safe and practical protocol for high-risk patients. J Allergy Clin Immunol 2002;110:928–933.
21. Muller UR, Jutel M, Reimers A, Zumkehr J, Huber C, Kriegel C et al. Clinical and immunologic effects of H1 antihistamine preventive medication during honeybee venom immunotherapy. J Allergy Clin Immunol 2008;122:1001–1007.
22. Garrone P, Neidhardt EM, Garcia E, Galibert L, van Kooten C, Banchereau J. Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med 1995;182:1265–1273.
23. Fink K. Origin and function of circulating plasmablasts during acute viral infections. Front Immunol 2012;3:78.
24. van de Veen W, Stanic B, Yaman G, Wawrzyniak M, Sollner S, Akdis DG et al. IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses. J Allergy Clin Immunol 2013;131:1204–1212.
25. Franz B, May KF Jr, Dranoff G, Wucherpfennig K. Ex vivo characterization and isolation of rare memory B cells with antigen tetramers. Blood 2011;118:348–357.
26. Patil SU, Ogunniyi AO, Calatroni A, Tadigotla VR, Ruiter B, Ma A et al. Peanut oral immunotherapy transiently expands circulating Ara h 2-specific B cells with a homologous repertoire in unrelated subjects. J Allergy Clin Immunol 2015;136:125–134.
27. Kaminski DA, Wei C, Qian Y, Rosenberg AF, Sanz I. Advances in human B cell phenotypic profiling. Front Immunol 2012;3:302.
28. Zaleska A, Eiwegger T, Soyer O, van de Veen W, Rhyner C, Soyka MB et al. Immune regulation by intralymphatic immunotherapy with modular allergen translocation MAT vaccine. Allergy 2014;69:1162–1170.
29. Nozawa A, Okamoto Y, Moverare R, Borres MP, Kurihara K. Monitoring Ara h 1, 2 and 3-sIgE and sIgG4 antibodies in peanut allergic children receiving oral rush immunotherapy. Pediatr Allergy Immunol 2014;25:323–328.
30. van der Neut Kolfschoten M, Schuurman J, Losen M, Bleeker WK, Martinez-Martinez P, Vermeulen E et al. Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science 2007;317:1554–1557.
31. Flinterman AE, Knol EF, Lencer DA, Bardina L, den Hartog Jager CF, Lin J et al. Peanut epitopes for IgE and IgG4 in peanut-sensitized children in relation to severity of peanut allergy. J Allergy Clin Immunol 2008;121:737–743.
32. Bogh KL, Nielsen H, Eiwegger T, Madsen CB, Mills EN, Rigby NM et al. IgE versus IgG4 epitopes of the peanut allergen Ara h 1 in patients with severe allergy. Mol Immunol 2014;58:169–176.
33. Strait RT, Morris SC, Finkelman FD. IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and Fc gamma RIIb cross-linking. J Clin Invest 2006;116:833–841.
34. Reginald K, Eckl-Dorna J, Zafred D, Focke-Tejkl M, Lupinek C, Niederberger V et al. Different modes of IgE binding to CD23 revealed with major birch allergen, Bet v 1-specific monoclonal IgE. Immunol Cell Biol 2013;91:167–172.
35. Xiong H, Dolpady J, Wabl M, Curotto de Lafaille MA, Lafaille JJ. Sequential class switching is required for the generation of high affinity IgE antibodies. J Exp Med 2012;209:353–364.
36. Berkowska MA, Heeringa JJ, Hajdarbegovic E, van der Burg M, Thio HB, van Hagen PM et al. Human IgE(+) B cells are derived from T cell-dependent and T cell-independent pathways. J Allergy Clin Immunol 2014;134:688–697.
37. Laffleur B, Duchez S, Tarte K, Denis-Lagache N, Peron S, Carrion C et al. Self-restrained B cells arise following membrane IgE expression. Cell Rep 2015;10:900–909.
38. Amu S, Saunders SP, Kronenberg M, Mangan NE, Atzberger A, Fallon PG. Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model. J Allergy Clin Immunol 2010;125:1114–1124.
39. Lundy SK, Berlin AA, Martens TF, Lukacs NW. Deficiency of regulatory B cells increases allergic airway inflammation. Inflamm Res 2005;54:514–521.
40. Kessel A, Haj T, Peri R, Snir A, Melamed D, Sabo E et al. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells. Autoimmun Rev 2012;11:670–677.
41. Lee KM, Stott RT, Zhao G, SooHoo J, Xiong W, Lian MM et al. TGF-beta-producing regulatory B cells induce regulatory T cells and promote transplantation tolerance. Eur J Immunol 2014;44:1728–1736.
42. Braza F, Chesne J, Castagnet S, Magnan A, Brouard S. Regulatory functions of B cells in allergic diseases. Allergy 2014;69:1454–1463.
43. Liu ZQ, Wu Y, Song JP, Liu X, Liu Z, Zheng PY et al. Tolerogenic CX3CR1+ B cells suppress food allergy-induced intestinal inflammation in mice. Allergy 2013;68:1241–1248.
44. Gawlik R, Gluck J, Jawor B, Rogala B. Effects of venom immunotherapy on serum level of CCL5/RANTES in patients with Hymenoptera venom allergy. Immunopharmacol Immunotoxicol 2015;37:375–379.